{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:54:56Z","timestamp":1790736896198,"version":"4.1.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T00:00:00Z","timestamp":1723852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T00:00:00Z","timestamp":1723852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG054008"],"award-info":[{"award-number":["R01AG054008"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["RF1NS095252"],"award-info":[{"award-number":["RF1NS095252"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30AG066514"],"award-info":[{"award-number":["P30AG066514"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG062348"],"award-info":[{"award-number":["R01AG062348"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["K01AG070326"],"award-info":[{"award-number":["K01AG070326"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["T35AG067578"],"award-info":[{"award-number":["T35AG067578"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS086736"],"award-info":[{"award-number":["R01NS086736"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U54NS115266"],"award-info":[{"award-number":["U54NS115266"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U54NS123743"],"award-info":[{"award-number":["U54NS123743"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016948","name":"Tau Consortium","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016948","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008539","name":"CurePSP","doi-asserted-by":"publisher","award":["685\u20132023-06"],"award-info":[{"award-number":["685\u20132023-06"]}],"id":[{"id":"10.13039\/100008539","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Stuart Katz"},{"name":"Jane Martin"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Progressive supranuclear palsy (PSP) is a neurodegenerative movement and cognitive disorder characterized by abnormal accumulation of the microtubule-associated protein tau in the brain. Biochemically, inclusions in PSP are enriched for tau proteoforms with four microtubule-binding domain repeats (4R), an isoform that arises from alternative tau pre-mRNA splicing. While preferential aggregation and reduced degradation of 4R tau protein is thought to play a role in inclusion formation and toxicity, an alternative hypothesis is that altered expression of tau mRNA isoforms plays a causal role. This stems from the observation that PSP is associated with common variation in the tau gene (\n                    <jats:italic>MAPT<\/jats:italic>\n                    ) at the 17q21.31 locus which contains low copy number repeats flanking a large recurrent genomic inversion. The complex genomic structural changes at the locus give rise to two dominant haplotypes, termed H1 and H2, that have the potential to markedly influence gene expression. Here, we explored haplotype-dependent differences in gene expression using a bulk RNA-seq dataset derived from human post-mortem brain tissue from PSP (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200984) and controls (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200977) using a rigorous computational pipeline, including alternative pre-mRNA splicing. We found 3579 differentially expressed genes in the temporal cortex and 10,011 in the cerebellum. We also found 7214 differential splicing events in the temporal cortex and 18,802 in the cerebellum. In the cerebellum, total tau mRNA levels and the proportion of transcripts encoding 4R tau were significantly increased in PSP compared to controls. In the temporal cortex, the proportion of reads that expressed 4R tau was increased in cases compared to controls. 4R tau mRNA levels were significantly associated with the H1 haplotype in the temporal cortex. Further, we observed a marked haplotype-dependent difference in\n                    <jats:italic>KANSL1<\/jats:italic>\n                    expression that was strongly associated with H1 in both brain regions. These findings support the hypothesis that sporadic PSP is associated with haplotype-dependent increases in 4R tau mRNA that might play a causal role in this disorder.\n                  <\/jats:p>","DOI":"10.1186\/s40478-024-01839-3","type":"journal-article","created":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T04:02:26Z","timestamp":1723867346000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["MAPT haplotype-associated transcriptomic changes in progressive supranuclear palsy"],"prefix":"10.1186","volume":"12","author":[{"given":"Hadley W.","family":"Ressler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Humphrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo A.","family":"Vialle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bergan","family":"Babrowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shrishtee","family":"Kandoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Towfique","family":"Raj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis W.","family":"Dickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nil\u00fcfer","family":"Ertekin-Taner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0556-293X","authenticated-orcid":false,"given":"John F.","family":"Crary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6955-7278","authenticated-orcid":false,"given":"Kurt","family":"Farrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,17]]},"reference":[{"key":"1839_CR1","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/B978-0-12-802395-2.00025-0","volume":"145","author":"GG Kovacs","year":"2017","unstructured":"Kovacs GG (2017) Tauopathies. Handb Clin Neurol 145:355\u2013368. https:\/\/doi.org\/10.1016\/B978-0-12-802395-2.00025-0","journal-title":"Handb Clin Neurol"},{"key":"1839_CR2","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb8255","author":"CW Chang","year":"2021","unstructured":"Chang CW, Shao E, Mucke L (2021) Tau: enabler of diverse brain disorders and target of rapidly evolving therapeutic strategies. Science. https:\/\/doi.org\/10.1126\/science.abb8255","journal-title":"Science."},{"issue":"1","key":"1839_CR3","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s13195-023-01321-7","volume":"15","author":"JL Cummings","year":"2023","unstructured":"Cummings JL, Gonzalez MI, Pritchard MC, May PC, Toledo-Sherman LM, Harris GA (2023) The therapeutic landscape of tauopathies: challenges and prospects. Alzheimers Res Ther 15(1):168. https:\/\/doi.org\/10.1186\/s13195-023-01321-7","journal-title":"Alzheimers Res Ther"},{"key":"1839_CR4","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.parkreldis.2021.09.008","volume":"90","author":"E Leveille","year":"2021","unstructured":"Leveille E, Ross OA, Gan-Or Z (2021) Tau and MAPT genetics in tauopathies and synucleinopathies. Parkinsonism Relat Disord 90:142\u2013154. https:\/\/doi.org\/10.1016\/j.parkreldis.2021.09.008","journal-title":"Parkinsonism Relat Disord"},{"issue":"6","key":"1839_CR5","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1002\/ana.410430617","volume":"43","author":"P Poorkaj","year":"1998","unstructured":"Poorkaj P, Bird TD, Wijsman E, Nemens E, Garruto RM, Anderson L et al (1998) Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann Neurol 43(6):815\u2013825. https:\/\/doi.org\/10.1002\/ana.410430617","journal-title":"Ann Neurol"},{"issue":"1","key":"1839_CR6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/nan.12213","volume":"41","author":"B Ghetti","year":"2015","unstructured":"Ghetti B, Oblak AL, Boeve BF, Johnson KA, Dickerson BC, Goedert M (2015) Invited review: frontotemporal dementia caused by microtubule-associated protein tau gene (MAPT) mutations: a chameleon for neuropathology and neuroimaging. Neuropathol Appl Neurobiol 41(1):24\u201346. https:\/\/doi.org\/10.1111\/nan.12213","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"6686","key":"1839_CR7","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/31508","volume":"393","author":"M Hutton","year":"1998","unstructured":"Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H et al (1998) Association of missense and 5\u2019-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393(6686):702\u2013705. https:\/\/doi.org\/10.1038\/31508","journal-title":"Nature"},{"key":"1839_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232315383","author":"A Corsi","year":"2022","unstructured":"Corsi A, Bombieri C, Valenti MT, Romanelli MG (2022) Tau isoforms: gaining insight into MAPT alternative splicing. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms232315383","journal-title":"Int J Mol Sci."},{"issue":"6","key":"1839_CR9","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/BF00296367","volume":"81","author":"S Flament","year":"1991","unstructured":"Flament S, Delacourte A, Verny M, Hauw JJ, Javoy-Agid F (1991) Abnormal Tau proteins in progressive supranuclear palsy. Similarities and differences with the neurofibrillary degeneration of the Alzheimer type. Acta Neuropathol. 81(6):591\u2013596. https:\/\/doi.org\/10.1007\/BF00296367","journal-title":"Acta Neuropathol."},{"issue":"2","key":"1839_CR10","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/s0169-328x(02)00382-0","volume":"104","author":"M Takanashi","year":"2002","unstructured":"Takanashi M, Mori H, Arima K, Mizuno Y, Hattori N (2002) Expression patterns of tau mRNA isoforms correlate with susceptible lesions in progressive supranuclear palsy and corticobasal degeneration. Brain Res Mol Brain Res 104(2):210\u2013219. https:\/\/doi.org\/10.1016\/s0169-328x(02)00382-0","journal-title":"Brain Res Mol Brain Res"},{"issue":"4","key":"1839_CR11","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/0896-6273(89)90210-9","volume":"3","author":"M Goedert","year":"1989","unstructured":"Goedert M, Spillantini MG, Jakes R, Rutherford D, Crowther RA (1989) Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer\u2019s disease. Neuron 3(4):519\u2013526. https:\/\/doi.org\/10.1016\/0896-6273(89)90210-9","journal-title":"Neuron"},{"issue":"2","key":"1839_CR12","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/j.1460-2075.1989.tb03390.x","volume":"8","author":"M Goedert","year":"1989","unstructured":"Goedert M, Spillantini MG, Potier MC, Ulrich J, Crowther RA (1989) Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain. EMBO J 8(2):393\u2013399. https:\/\/doi.org\/10.1002\/j.1460-2075.1989.tb03390.x","journal-title":"EMBO J"},{"issue":"43","key":"1839_CR13","doi-asserted-by":"publisher","first-page":"10626","DOI":"10.1021\/bi00158a027","volume":"31","author":"A Andreadis","year":"1992","unstructured":"Andreadis A, Brown WM, Kosik KS (1992) Structure and novel exons of the human tau gene. Biochemistry 31(43):10626\u201310633. https:\/\/doi.org\/10.1021\/bi00158a027","journal-title":"Biochemistry"},{"issue":"2\u20133","key":"1839_CR14","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/s0014-5793(99)00222-7","volume":"446","author":"R Dayanandan","year":"1999","unstructured":"Dayanandan R, Van Slegtenhorst M, Mack TG, Ko L, Yen SH, Leroy K et al (1999) Mutations in tau reduce its microtubule binding properties in intact cells and affect its phosphorylation. FEBS Lett 446(2\u20133):228\u2013232. https:\/\/doi.org\/10.1016\/s0014-5793(99)00222-7","journal-title":"FEBS Lett"},{"issue":"7","key":"1839_CR15","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/ng.859","volume":"43","author":"GU Hoglinger","year":"2011","unstructured":"Hoglinger GU, Melhem NM, Dickson DW, Sleiman PM, Wang LS, Klei L et al (2011) Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. Nat Genet 43(7):699\u2013705. https:\/\/doi.org\/10.1038\/ng.859","journal-title":"Nat Genet"},{"key":"1839_CR16","doi-asserted-by":"publisher","DOI":"10.1101\/2023.12.28.23300612","author":"H Wang","year":"2024","unstructured":"Wang H, Chang TS, Dombroski BA, Cheng PL, Patil V, Valiente-Banuet L et al (2024) Whole-genome sequencing analysis reveals new susceptibility loci and structural variants associated with progressive supranuclear palsy. medRxiv. https:\/\/doi.org\/10.1101\/2023.12.28.23300612","journal-title":"medRxiv."},{"key":"1839_CR17","doi-asserted-by":"publisher","DOI":"10.1101\/2023.11.09.565552","author":"K Farrell","year":"2023","unstructured":"Farrell K, Humphrey J, Chang T, Zhao Y, Leung YY, Kuksa PP et al (2023) Genetic, transcriptomic, histological, and biochemical analysis of progressive supranuclear palsy implicates glial activation and novel risk genes. bioRxiv. https:\/\/doi.org\/10.1101\/2023.11.09.565552","journal-title":"bioRxiv"},{"issue":"4","key":"1839_CR18","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1093\/hmg\/8.4.711","volume":"8","author":"M Baker","year":"1999","unstructured":"Baker M, Litvan I, Houlden H, Adamson J, Dickson D, Perez-Tur J et al (1999) Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum Mol Genet 8(4):711\u2013715. https:\/\/doi.org\/10.1093\/hmg\/8.4.711","journal-title":"Hum Mol Genet"},{"issue":"8","key":"1839_CR19","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/ng.2334","volume":"44","author":"LM Boettger","year":"2012","unstructured":"Boettger LM, Handsaker RE, Zody MC, McCarroll SA (2012) Structural haplotypes and recent evolution of the human 17q21.31 region. Nat Genet. 44(8):881\u2013885. https:\/\/doi.org\/10.1038\/ng.2334","journal-title":"Nat Genet."},{"issue":"1","key":"1839_CR20","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13024-022-00551-x","volume":"17","author":"KR Bowles","year":"2022","unstructured":"Bowles KR, Pugh DA, Liu Y, Patel T, Renton AE, Bandres-Ciga S et al (2022) 17q21.31 sub-haplotypes underlying H1-associated risk for Parkinson\u2019s disease are associated with LRRC37A\/2 expression in astrocytes. Mol Neurodegener. 17(1):48. https:\/\/doi.org\/10.1186\/s13024-022-00551-x","journal-title":"Mol Neurodegener."},{"issue":"1","key":"1839_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2007.04.006","volume":"27","author":"TM Caffrey","year":"2007","unstructured":"Caffrey TM, Wade-Martins R (2007) Functional haplotypes: bridging the gap between genotype and neuropathology. Neurobiol Dis 27(1):1\u201310. https:\/\/doi.org\/10.1016\/j.nbd.2007.04.006","journal-title":"Neurobiol Dis"},{"issue":"3","key":"1839_CR22","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.nbd.2006.10.018","volume":"25","author":"AJ Myers","year":"2007","unstructured":"Myers AJ, Pittman AM, Zhao AS, Rohrer K, Kaleem M, Marlowe L et al (2007) The H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts. Neurobiol Dis 25(3):561\u2013570. https:\/\/doi.org\/10.1016\/j.nbd.2006.10.018","journal-title":"Neurobiol Dis"},{"issue":"9","key":"1839_CR23","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1038\/ng.193","volume":"40","author":"MC Zody","year":"2008","unstructured":"Zody MC, Jiang Z, Fung HC, Antonacci F, Hillier LW, Cardone MF et al (2008) Evolutionary toggling of the MAPT 17q21.31 inversion region. Nat Genet. 40(9):1076\u20131083. https:\/\/doi.org\/10.1038\/ng.193","journal-title":"Nat Genet."},{"issue":"1","key":"1839_CR24","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13024-024-00731-x","volume":"19","author":"C Pedicone","year":"2024","unstructured":"Pedicone C, Weitzman SA, Renton AE, Goate AM (2024) Unraveling the complex role of MAPT-containing H1 and H2 haplotypes in neurodegenerative diseases. Mol Neurodegener 19(1):43. https:\/\/doi.org\/10.1186\/s13024-024-00731-x","journal-title":"Mol Neurodegener"},{"key":"1839_CR25","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2021.0209","author":"E Campoy","year":"2022","unstructured":"Campoy E, Puig M, Yakymenko I, Lerga-Jaso J, Caceres M (2022) Genomic architecture and functional effects of potential human inversion supergenes. Philos Trans R Soc B. https:\/\/doi.org\/10.1098\/rstb.2021.0209","journal-title":"Philos Trans R Soc B"},{"issue":"4","key":"1839_CR26","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s00401-006-0048-x","volume":"111","author":"R de Silva","year":"2006","unstructured":"de Silva R, Lashley T, Strand C, Shiarli AM, Shi J, Tian JZ et al (2006) An immunohistochemical study of cases of sporadic and inherited frontotemporal lobar degeneration using 3R-and 4R-specific tau monoclonal antibodies. Acta Neuropathol 111(4):329\u2013340. https:\/\/doi.org\/10.1007\/s00401-006-0048-x","journal-title":"Acta Neuropathol"},{"key":"1839_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.581936","author":"F Kametani","year":"2020","unstructured":"Kametani F, Yoshida M, Matsubara T, Murayama S, Saito Y, Kawakami I et al (2020) Comparison of common and disease-specific post-translational modifications of pathological Tau associated with a wide range of tauopathies. Front Neurosci-Switz. https:\/\/doi.org\/10.3389\/fnins.2020.581936","journal-title":"Front Neurosci-Switz"},{"issue":"4","key":"1839_CR28","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s00401-022-02479-4","volume":"144","author":"SF Roemer","year":"2022","unstructured":"Roemer SF, Grinberg LT, Crary JF, Seeley WW, McKee AC, Kovacs GG et al (2022) Rainwater Charitable Foundation criteria for the neuropathologic diagnosis of progressive supranuclear palsy. Acta Neuropathol 144(4):603\u2013614. https:\/\/doi.org\/10.1007\/s00401-022-02479-4","journal-title":"Acta Neuropathol"},{"issue":"3","key":"1839_CR29","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/1531-8249(199909)46:3<325::aid-ana8>3.0.co;2-v","volume":"46","author":"CB Chambers","year":"1999","unstructured":"Chambers CB, Lee JM, Troncoso JC, Reich S, Muma NA (1999) Overexpression of four-repeat tau mRNA isoforms in progressive supranuclear palsy but not in Alzheimer\u2019s disease. Ann Neurol 46(3):325\u2013332. https:\/\/doi.org\/10.1002\/1531-8249(199909)46:3%3c325::aid-ana8%3e3.0.co;2-v","journal-title":"Ann Neurol"},{"issue":"5","key":"1839_CR30","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s00401-007-0280-z","volume":"114","author":"M Ingelsson","year":"2007","unstructured":"Ingelsson M, Ramasamy K, Russ C, Freeman SH, Orne J, Raju S et al (2007) Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains. Acta Neuropathol 114(5):471\u2013479. https:\/\/doi.org\/10.1007\/s00401-007-0280-z","journal-title":"Acta Neuropathol"},{"key":"1839_CR31","doi-asserted-by":"publisher","DOI":"10.1101\/2023.09.29.560245","author":"JE Rexach","year":"2023","unstructured":"Rexach JE, Cheng Y, Chen L, Polioudakis D, Lin LC, Mitri V et al (2023) Disease-specific selective vulnerability and neuroimmune pathways in dementia revealed by single cell genomics. bioRxiv. https:\/\/doi.org\/10.1101\/2023.09.29.560245","journal-title":"bioRxiv"},{"key":"1839_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-13-458","author":"S de Jong","year":"2012","unstructured":"de Jong S, Chepelev I, Janson E, Strengman E, van den Berg LH, Veldink JH et al (2012) Common inversion polymorphism at 17q21.31 affects expression of multiple genes in tissue-specific manner. BMC Genomics. https:\/\/doi.org\/10.1186\/1471-2164-13-458","journal-title":"BMC Genomics"},{"issue":"1","key":"1839_CR33","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s40478-023-01534-9","volume":"11","author":"CV Tauber","year":"2023","unstructured":"Tauber CV, Schwarz SC, R\u00f6sler TW, Arzberger T, Gentleman S, Windl O et al (2023) Different MAPT haplotypes influence expression of total MAPT in postmortem brain tissue. Acta Neuropathol Commun 11(1):40. https:\/\/doi.org\/10.1186\/s40478-023-01534-9","journal-title":"Acta Neuropathol Commun"},{"key":"1839_CR34","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1472-6750-8-48","volume":"8","author":"T Naiser","year":"2008","unstructured":"Naiser T, Ehler O, Kayser J, Mai T, Michel W, Ott A (2008) Impact of point-mutations on the hybridization affinity of surface-bound DNA\/DNA and RNA\/DNA oligonucleotide-duplexes: comparison of single base mismatches and base bulges. BMC Biotechnol 8:48. https:\/\/doi.org\/10.1186\/1472-6750-8-48","journal-title":"BMC Biotechnol"},{"issue":"18","key":"1839_CR35","doi-asserted-by":"publisher","first-page":"4094","DOI":"10.1093\/hmg\/dds238","volume":"21","author":"D Trabzuni","year":"2012","unstructured":"Trabzuni D, Wray S, Vandrovcova J, Ramasamy A, Walker R, Smith C et al (2012) expression and splicing is differentially regulated by brain region: relation to genotype and implication for tauopathies. Hum Mol Genet 21(18):4094\u20134103. https:\/\/doi.org\/10.1093\/hmg\/dds238","journal-title":"Hum Mol Genet"},{"issue":"2","key":"1839_CR36","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00401-016-1576-7","volume":"132","author":"M Allen","year":"2016","unstructured":"Allen M, Burgess JD, Ballard T, Serie D, Wang X, Younkin CS et al (2016) Gene expression, methylation and neuropathology correlations at progressive supranuclear palsy risk loci. Acta Neuropathol 132(2):197\u2013211. https:\/\/doi.org\/10.1007\/s00401-016-1576-7","journal-title":"Acta Neuropathol"},{"issue":"5","key":"1839_CR37","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s00401-012-1017-1","volume":"124","author":"I Santa-Maria","year":"2012","unstructured":"Santa-Maria I, Haggiagi A, Liu XM, Wasserscheid J, Nelson PT, Dewar K et al (2012) The H1 haplotype is associated with tangle-predominant dementia. Acta Neuropathol 124(5):693\u2013704. https:\/\/doi.org\/10.1007\/s00401-012-1017-1","journal-title":"Acta Neuropathol"},{"key":"1839_CR38","unstructured":"Shah H, CW Y, Castellanos R, Pandya C, Giles Z (eds) (2015) RAPiD\u2014an agile and dependable RNA-Seq framework. In: The 65th annual meeting of The American Society of Human Genetics"},{"issue":"15","key":"1839_CR39","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger AM, Lohse M, Usadel B (2014) Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30(15):2114\u20132120. https:\/\/doi.org\/10.1093\/bioinformatics\/btu170","journal-title":"Bioinformatics"},{"issue":"1","key":"1839_CR40","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S et al (2013) STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29(1):15\u201321. https:\/\/doi.org\/10.1093\/bioinformatics\/bts635","journal-title":"Bioinformatics"},{"key":"1839_CR41","unstructured":"FastQC (2015)"},{"issue":"7","key":"1839_CR42","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao Y, Smyth GK, Shi W (2014) featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30(7):923\u2013930. https:\/\/doi.org\/10.1093\/bioinformatics\/btt656","journal-title":"Bioinformatics"},{"key":"1839_CR43","unstructured":"Institute B. Picard (2023)"},{"key":"1839_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-12-323","author":"B Li","year":"2011","unstructured":"Li B, Dewey CN (2011) RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinform. https:\/\/doi.org\/10.1186\/1471-2105-12-323","journal-title":"BMC Bioinform"},{"issue":"1","key":"1839_CR45","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41588-017-0004-9","volume":"50","author":"YI Li","year":"2018","unstructured":"Li YI, Knowles DA, Humphrey J, Barbeira AN, Dickinson SP, Im HK et al (2018) Annotation-free quantification of RNA splicing using LeafCutter. Nat Genet 50(1):151\u2013158. https:\/\/doi.org\/10.1038\/s41588-017-0004-9","journal-title":"Nat Genet"},{"issue":"2","key":"1839_CR46","doi-asserted-by":"publisher","first-page":"R29","DOI":"10.1186\/gb-2014-15-2-r29","volume":"15","author":"CW Law","year":"2014","unstructured":"Law CW, Chen Y, Shi W, Smyth GK (2014) voom: precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol 15(2):R29. https:\/\/doi.org\/10.1186\/gb-2014-15-2-r29","journal-title":"Genome Biol"},{"issue":"1","key":"1839_CR47","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1186\/s12859-016-1323-z","volume":"17","author":"GE Hoffman","year":"2016","unstructured":"Hoffman GE, Schadt EE (2016) variancePartition: interpreting drivers of variation in complex gene expression studies. BMC Bioinform 17(1):483. https:\/\/doi.org\/10.1186\/s12859-016-1323-z","journal-title":"BMC Bioinform"},{"issue":"6","key":"1839_CR48","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1093\/bioinformatics\/btp053","volume":"25","author":"DJ McCarthy","year":"2009","unstructured":"McCarthy DJ, Smyth GK (2009) Testing significance relative to a fold-change threshold is a TREAT. Bioinformatics 25(6):765\u2013771. https:\/\/doi.org\/10.1093\/bioinformatics\/btp053","journal-title":"Bioinformatics"},{"issue":"1","key":"1839_CR49","doi-asserted-by":"publisher","first-page":"8868","DOI":"10.1038\/s41598-018-27293-5","volume":"8","author":"AT McKenzie","year":"2018","unstructured":"McKenzie AT, Wang M, Hauberg ME, Fullard JF, Kozlenkov A, Keenan A et al (2018) Brain cell type specific gene expression and co-expression network architectures. Sci Rep 8(1):8868. https:\/\/doi.org\/10.1038\/s41598-018-27293-5","journal-title":"Sci Rep"},{"key":"1839_CR50","doi-asserted-by":"publisher","first-page":"160089","DOI":"10.1038\/sdata.2016.89","volume":"3","author":"M Allen","year":"2016","unstructured":"Allen M, Carrasquillo MM, Funk C, Heavner BD, Zou F, Younkin CS et al (2016) Human whole genome genotype and transcriptome data for Alzheimer\u2019s and other neurodegenerative diseases. Sci Data 3:160089. https:\/\/doi.org\/10.1038\/sdata.2016.89","journal-title":"Sci Data"},{"issue":"2","key":"1839_CR51","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1002\/ana.410410222","volume":"41","author":"C Conrad","year":"1997","unstructured":"Conrad C, Andreadis A, Trojanowski JQ, Dickson DW, Kang D, Chen X et al (1997) Genetic evidence for the involvement of tau in progressive supranuclear palsy. Ann Neurol 41(2):277\u2013281. https:\/\/doi.org\/10.1002\/ana.410410222","journal-title":"Ann Neurol"},{"issue":"1","key":"1839_CR52","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00401-021-02379-z","volume":"143","author":"K Farrell","year":"2022","unstructured":"Farrell K, Kim S, Han N, Iida MA, Gonzalez EM, Otero-Garcia M et al (2022) Genome-wide association study and functional validation implicates JADE1 in tauopathy. Acta Neuropathol 143(1):33\u201353. https:\/\/doi.org\/10.1007\/s00401-021-02379-z","journal-title":"Acta Neuropathol"},{"issue":"1","key":"1839_CR53","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13024-018-0270-8","volume":"13","author":"JA Chen","year":"2018","unstructured":"Chen JA, Chen Z, Won H, Huang AY, Lowe JK, Wojta K et al (2018) Joint genome-wide association study of progressive supranuclear palsy identifies novel susceptibility loci and genetic correlation to neurodegenerative diseases. Mol Neurodegener 13(1):41. https:\/\/doi.org\/10.1186\/s13024-018-0270-8","journal-title":"Mol Neurodegener"},{"issue":"2","key":"1839_CR54","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S1474-4422(20)30394-X","volume":"20","author":"E Jabbari","year":"2021","unstructured":"Jabbari E, Koga S, Valentino RR, Reynolds RH, Ferrari R, Tan MMX et al (2021) Genetic determinants of survival in progressive supranuclear palsy: a genome-wide association study. Lancet Neurol 20(2):107\u2013116. https:\/\/doi.org\/10.1016\/S1474-4422(20)30394-X","journal-title":"Lancet Neurol"},{"key":"1839_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-018-0267-3","author":"MY Sanchez-Contreras","year":"2018","unstructured":"Sanchez-Contreras MY, Kouri N, Cook CN, Serie DJ, Heckman MG, Finch NA et al (2018) Replication of progressive supranuclear palsy genome-wide association study identifies and as new susceptibility loci. Mol Neurodegener. https:\/\/doi.org\/10.1186\/s13024-018-0267-3","journal-title":"Mol Neurodegener"},{"issue":"5","key":"1839_CR56","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S1474-4422(24)00083-8","volume":"23","author":"RR Valentino","year":"2024","unstructured":"Valentino RR, Scotton WJ, Roemer SF, Lashley T, Heckman MG, Shoai M et al (2024) MAPT H2 haplotype and risk of Pick\u2019s disease in the Pick\u2019s disease International Consortium: a genetic association study. Lancet Neurol 23(5):487\u2013499. https:\/\/doi.org\/10.1016\/S1474-4422(24)00083-8","journal-title":"Lancet Neurol"},{"key":"1839_CR57","doi-asserted-by":"publisher","first-page":"7247","DOI":"10.1038\/ncomms8247","volume":"6","author":"N Kouri","year":"2015","unstructured":"Kouri N, Ross OA, Dombroski B, Younkin CS, Serie DJ, Soto-Ortolaza A et al (2015) Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy. Nat Commun 6:7247. https:\/\/doi.org\/10.1038\/ncomms8247","journal-title":"Nat Commun"},{"issue":"7","key":"1839_CR58","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1002\/alz.12099","volume":"16","author":"SL Strickland","year":"2020","unstructured":"Strickland SL, Reddy JS, Allen M, N\u2019Songo A, Burgess JD, Corda MM et al (2020) MAPT haplotype-stratified GWAS reveals differential association for AD risk variants. Alzheimers Dement 16(7):983\u20131002. https:\/\/doi.org\/10.1002\/alz.12099","journal-title":"Alzheimers Dement"},{"issue":"4","key":"1839_CR59","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/alzrt268","volume":"6","author":"M Allen","year":"2014","unstructured":"Allen M, Kachadoorian M, Quicksall Z, Zou F, Chai HS, Younkin C et al (2014) Association of MAPT haplotypes with Alzheimer\u2019s disease risk and MAPT brain gene expression levels. Alzheimers Res Ther 6(4):39. https:\/\/doi.org\/10.1186\/alzrt268","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"1839_CR60","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s40478-020-01097-z","volume":"8","author":"RR Valentino","year":"2020","unstructured":"Valentino RR, Koga S, Walton RL, Soto-Beasley AI, Kouri N, DeTure MA et al (2020) MAPT subhaplotypes in corticobasal degeneration: assessing associations with disease risk, severity of tau pathology, and clinical features. Acta Neuropathol Commun 8(1):218. https:\/\/doi.org\/10.1186\/s40478-020-01097-z","journal-title":"Acta Neuropathol Commun"},{"issue":"2","key":"1839_CR61","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00401-021-02320-4","volume":"142","author":"D Wallon","year":"2021","unstructured":"Wallon D, Boluda S, Rovelet-Lecrux A, Thierry M, Lagarde J, Miguel L et al (2021) Clinical and neuropathological diversity of tauopathy in MAPT duplication carriers. Acta Neuropathol 142(2):259\u2013278. https:\/\/doi.org\/10.1007\/s00401-021-02320-4","journal-title":"Acta Neuropathol"},{"issue":"1","key":"1839_CR62","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1159\/000452724","volume":"150","author":"C Ciaccio","year":"2016","unstructured":"Ciaccio C, Dordoni C, Ritelli M, Colombi M (2016) Koolen\u2013de Vries syndrome: clinical report of an adult and literature review. Cytogenet Genome Res 150(1):40\u201345. https:\/\/doi.org\/10.1159\/000452724","journal-title":"Cytogenet Genome Res"},{"issue":"5","key":"1839_CR63","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/ejhg.2015.178","volume":"24","author":"DA Koolen","year":"2016","unstructured":"Koolen DA, Pfundt R, Linda K, Beunders G, Veenstra-Knol HE, Conta JH et al (2016) The Koolen\u2013de Vries syndrome: a phenotypic comparison of patients with a 17q21.31 microdeletion versus a KANSL1 sequence variant. Eur J Hum Genet. 24(5):652\u2013659. https:\/\/doi.org\/10.1038\/ejhg.2015.178","journal-title":"Eur J Hum Genet."},{"issue":"11","key":"1839_CR64","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1002\/humu.24467","volume":"43","author":"F Brand","year":"2022","unstructured":"Brand F, Vijayananth A, Hsieh TC, Schmidt A, Peters S, Mangold E et al (2022) Next-generation phenotyping contributing to the identification of a 4.7 kb deletion in KANSL1 causing Koolen\u2013de Vries syndrome. Hum Mutat. 43(11):1659\u20131665. https:\/\/doi.org\/10.1002\/humu.24467","journal-title":"Hum Mutat."},{"issue":"7","key":"1839_CR65","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.braindev.2016.02.002","volume":"38","author":"P Bernardo","year":"2016","unstructured":"Bernardo P, Madia F, Santulli L, Del Gaudio L, Caccavale C, Zara F et al (2016) 17q21.31 microdeletion syndrome: description of a case further contributing to the delineation of Koolen\u2013de Vries syndrome. Brain Dev-Jpn 38(7):663\u2013668. https:\/\/doi.org\/10.1016\/j.braindev.2016.02.002","journal-title":"Brain Dev-Jpn"},{"issue":"9","key":"1839_CR66","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1038\/ng0906-974","volume":"38","author":"JR Lupski","year":"2006","unstructured":"Lupski JR (2006) Genome structural variation and sporadic disease traits. Nat Genet 38(9):974\u2013976. https:\/\/doi.org\/10.1038\/ng0906-974","journal-title":"Nat Genet"},{"issue":"7","key":"1839_CR67","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1136\/jmg.2008.065391","volume":"46","author":"TY Tan","year":"2009","unstructured":"Tan TY, Aftimos S, Worgan L, Susman R, Wilson M, Ghedia S et al (2009) Phenotypic expansion and further characterisation of the 17q21.31 microdeletion syndrome. J Med Genet. 46(7):480\u2013489. https:\/\/doi.org\/10.1136\/jmg.2008.065391","journal-title":"J Med Genet."},{"key":"1839_CR68","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3389\/fnagi.2020.00096","volume":"12","author":"GG Kovacs","year":"2020","unstructured":"Kovacs GG (2020) Astroglia and tau: new perspectives. Front Aging Neurosci 12:96. https:\/\/doi.org\/10.3389\/fnagi.2020.00096","journal-title":"Front Aging Neurosci"},{"key":"1839_CR69","doi-asserted-by":"crossref","unstructured":"Forrest S, Lee S, Martinez-Valbuena I, Sackmann V, Li J, Ittner L, et al (2023) Cell-specific MAPT gene expression is preserved in neuronal and glial tau cytopathologies in progressive supranuclear palsy. Brain Pathol 33","DOI":"10.1007\/s00401-023-02604-x"},{"key":"1839_CR70","doi-asserted-by":"publisher","DOI":"10.1101\/2023.11.17.567587","author":"K Whitney","year":"2023","unstructured":"Whitney K, Song WM, Sharma A, Dangoor DK, Farrell K, Krassner MM et al (2023) Single-cell transcriptomic and neuropathologic analysis reveals dysregulation of the integrated stress response in progressive supranuclear palsy. bioRxiv. https:\/\/doi.org\/10.1101\/2023.11.17.567587","journal-title":"bioRxiv"},{"key":"1839_CR71","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aag0481","author":"SL DeVos","year":"2017","unstructured":"DeVos SL, Miller RL, Schoch KM, Holmes BB, Kebodeaux CS, Wegener AJ et al (2017) Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.aag0481","journal-title":"Sci Transl Med"},{"issue":"6","key":"1839_CR72","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1038\/s41591-023-02326-3","volume":"29","author":"CJ Mummery","year":"2023","unstructured":"Mummery CJ, B\u00f6rjesson-Hanson A, Blackburn DJ, Vijverberg EGB, De Deyn PP, Ducharme S et al (2023) Tau-targeting antisense oligonucleotide MAPT in mild Alzheimer\u2019s disease: a phase 1b, randomized, placebo-controlled trial. Nat Med 29(6):1437. https:\/\/doi.org\/10.1038\/s41591-023-02326-3","journal-title":"Nat Med"},{"issue":"6","key":"1839_CR73","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1093\/brain\/awad024","volume":"146","author":"H Florian","year":"2023","unstructured":"Florian H, Wang D, Arnold SE, Boada M, Guo Q, Jin Z et al (2023) Tilavonemab in early Alzheimer\u2019s disease: results from a phase 2, randomized, double-blind study. Brain 146(6):2275\u20132284. https:\/\/doi.org\/10.1093\/brain\/awad024","journal-title":"Brain"},{"issue":"14","key":"1839_CR74","doi-asserted-by":"publisher","first-page":"e1391","DOI":"10.1212\/WNL.0000000000207663","volume":"101","author":"C Monteiro","year":"2023","unstructured":"Monteiro C, Toth B, Brunstein F, Bobbala A, Datta S, Ceniceros R et al (2023) Randomized phase II study of the safety and efficacy of semorinemab in participants with mild-to-moderate Alzheimer disease: Lauriet. Neurology 101(14):e1391\u2013e1401. https:\/\/doi.org\/10.1212\/WNL.0000000000207663","journal-title":"Neurology"},{"issue":"1","key":"1839_CR75","doi-asserted-by":"publisher","first-page":"16806","DOI":"10.1038\/s41598-021-94708-1","volume":"11","author":"N Callizot","year":"2021","unstructured":"Callizot N, Estrella C, Burlet S, Henriques A, Brantis C, Barrier M et al (2021) AZP2006, a new promising treatment for Alzheimer\u2019s and related diseases. Sci Rep 11(1):16806. https:\/\/doi.org\/10.1038\/s41598-021-94708-1","journal-title":"Sci Rep"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-024-01839-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-024-01839-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-024-01839-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T04:07:44Z","timestamp":1723867664000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-024-01839-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,17]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1839"],"URL":"https:\/\/doi.org\/10.1186\/s40478-024-01839-3","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,17]]},"assertion":[{"value":"7 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors have consented for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"135"}}